7 results on '"Degener L"'
Search Results
2. Precision measurement of theg J factors of metastable atomic states of88Sr and138Ba using the atomic beam magnetic resonance method
- Author
-
Aydin, R., Aldenhoven, R., Degener, L., Gebauer, H., and Meisel, G.
- Published
- 1975
- Full Text
- View/download PDF
3. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
- Author
-
Kotseva, K., Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner, Željko, Keil U, EUROASPIRE Study Group. Collaborators: Pyörälä K, Ambrosio GB, Cokkinos D, Deckers JW, Dzerve V, Fraz Z, Gaita D, Gotcheva N, Graham I, Kotseva K, Laucevicius A, Lehto S, McGregor K, Nicolaides P, Oganov R, Ostör E, Pajak A, Simon J, Tokgözoğlu L, De Velasco J, Jenning C, Xenikaki D, Winnicki J, Manini M, Bramley C, Boulle C, Taylor C, Sundvall J, Lund L, De Sutter J, Piessens V, Van den Abbeele H, Dierickx E, Muylaert P, Present L, Braeckman M, Bruggeman H, Debackere P, Heytens S, Deleu K, Behaeghe P, Van De Wiele J, Van Aelst F, Taragola H, Spenninck E, Verkinderen B, Van Baeveghem S, De Waele B, De Waele C, Calis B, Schiettecatte V, Vermaercke C, Willems S, Van Imschoot K, De Vriese M, Maudens P, Maudens F, Georgiev B, Kastamanov R, Toneva K, Pavlov T, Stoev I, Alexandrov A, Miladinov A, Valterova A, Bergman-Marković, Biserka, Vinter-Repalust, Nevenka, Cerovečki Nekić, Venija, Soldo, Dragan, Petriček, Goranka, Ožvačić Adžić, Zlata, Marijić Gordana, Saloranta P, Savolainen J, Helminen EE, Heidrich J, Prugger C, Wellmann J, Neiteler G, Kalic M, Siebert E, Brand-Herrmann SM, Telgmann R, Barth F, Berger U, Briefs HJ, Degener L, Friedewald W, Heinemann-Vechtel O, Hüning U, Kalbfleisch C, Krösmann M, Neugebauer U, Noack KH, Richter-Millers B, Schuster A, Wahle K, Vanuzzo D, Mirolo R, Pilotto L, Zamaro G, Adinolfi V, Da Porto M, Gubiani M, Canciani L, Hansone S, Gozite A, Liepa L, Veze I, Putane L, Ecina V, Aija Rubine I, Rozkova N, Bricina N, Erglis A, Kawecka-Jaszcz K, Wolfshaut-Wolak R, Jankowski P, Windak A, Krzysztoń J, Makowiec-Dyrda M, Giza B, Sadek-Ratajewicz J, Sobalski T, Korman, Tomislav, Pop M, Buzulica C, Cicala C, Nicoara M, Zarici I, Iurciuc M, Iurciuc S, Roman C, Gavruta M, Breteanu L, Avram CA, Sarau CA, Avram C, Craciun L, Fras Z, Fras-Stefan T, Dovc M, Celan-Lucu B, Kralj S, Jurkovic G, Fonda A, Bercic MM, Maiques A, Mendez G, Buigues C, Montero N, Amoraga A, Bonet Y, Cuevas R, Torres Y, De Vries H, Koul B, Fellowes D, Sleight C, Purwar R, Harrison M, Saini S, Walton I, Thomas S, Igbanoi J, Bello F, Elgamel V, and Kudyba M.
- Subjects
Male ,medicine.medical_specialty ,Epidemiology ,Cross-sectional study ,medicine.medical_treatment ,General Practice ,MEDLINE ,Risk Assessment ,Asymptomatic ,Risk Factors ,Diabetes mellitus ,Environmental health ,EUROASPIRE ,guidelines ,primary prevention ,Preventive Health Services ,Weight Loss ,Diabetes Mellitus ,medicine ,Humans ,Hypoglycemic Agents ,Practice Patterns, Physicians' ,Antihypertensive Agents ,Aged ,Dyslipidemias ,Hypolipidemic Agents ,Retrospective Studies ,Asymptomatic Diseases ,business.industry ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Europe ,Cross-Sectional Studies ,Treatment Outcome ,Cardiovascular Diseases ,Health Care Surveys ,Hypertension ,Practice Guidelines as Topic ,Physical therapy ,Smoking cessation ,Female ,Smoking Cessation ,Guideline Adherence ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,Risk assessment ,business ,Risk Reduction Behavior - Abstract
Objective was to determine whether the 2003 Joint European Societies' guidelines on cardiovascular disease prevention in people at high cardiovascular risk have been followed in general practice. Design was Cross-sectional survey. The EUROASPIRE survey was carried out in 2006-2007 in 66 general practices in 12 European countries. Patients without a history of coronary or other atherosclerotic disease either started on antihypertensive and/or lipid-lowering and/or antidiabetes treatments were identified retrospectively, interviewed and examined at least 6 months after the start of medication. Four thousand, three hundred and sixty-six high- risk individuals (57.7% females) were interviewed (participation rate 76.7%). Overall, 16.9% smoked cigarettes, 43.5% had body mass index ≥30 kg/m, 70.8% had blood pressure ≥140/90 mmHg (≥130/80 in people with diabetes mellitus), 66.4% had total cholesterol ≥5.0 mmol/l (≥4.5 mmol/l in people with diabetes) and 30.2% reported a history of diabetes. The risk factor control was very poor, with only 26.3% of patients using antihypertensive medication achieving the blood pressure goal, 30.6% of patients on lipid-lowering medication achieving the total cholesterol goal and 39.9% of patients with self-reported diabetes having haemoglobin A1c ≤6.1%. The use of blood pressure- lowering medication in people with hypertension was: β-blockers 34.1%, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers 60.8%, calcium channel blockers 26.3%, diuretics 36.9%. Statins were prescribed in 47.0% of people with hypercholesterolemia. About 22.0% of all patients were on aspirin or other antiplatelet medication. The EUROASPIRE III survey in general practice shows that the lifestyle of people being treated as high cardiovascular risk is a major cause of concern with persistent smoking and high prevalence of both obesity and central obesity. Blood pressure, lipid and glucose control are completely inadequate with most patients not achieving the targets defined in the prevention guidelines. Primary prevention needs a systematic, comprehensive, multidisciplinary approach, which addresses lifestyle and risk factor management by general practitioners, nurses and other allied health professionals, and a health care system which invests in prevention.
- Published
- 2010
4. Spectral characteristics of protons in the Earth's plasmasheet: statistical results from Cluster CIS and RAPID.
- Author
-
Haaland, S., Kronberg, E. A., Daly, P. W., Fränz, M., Degener, L., Georgescu, E., and Dandouras, I.
- Subjects
PROTONS ,EARTH (Planet) ,GEOMAGNETISM ,SOLAR wind ,MAGNETIC fields ,IONS - Abstract
We present a study of the spectral characteristics of protons in the Earth's plasma sheet for various geomagnetic disturbance levels. The study is based on about 5400 h of data combined from the Cluster RAPID and CIS instruments obtained during the tail season (July-October). The overall proton spectral shape is generally that of a κ distribution, that is, resembling a Maxwellian at lower energies which smoothly merges into a power-law tail at higher energies. The actual spectral long-term slope depends on various magnetospheric driver parameters, but is on average around 3.5-4. During disturbed conditions, such as geomagnetic storm or substorm periods, a shift in the characteristic energy is observed. For two individual storms, we also found a hardening of the spectra. Unlike the electron spectra, we do not see any significant local time dependence in the spectral slope, but we find higher average ion fluxes in the dusk side. We also do not find any direct response in the energy spectra to changes in the interplanetary magnetic field or solar wind dynamic pressure. This suggests that energization of the ions are mainly due to internal processes in the plasma sheet. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
5. Precision measurement of the g factors of metastable atomic states ofSr andBa using the atomic beam magnetic resonance method.
- Author
-
Aydin, R., Aldenhoven, R., Degener, L., Gebauer, H., and Meisel, G.
- Abstract
The g factors of the metastable states P ofSr and D, D, D, and D ofBa have been measured using the atomic-beam magnetic resonance method. The metastable states were populated by an electric discharge within the atomic-beam source. From the measurements of rf transitions between the Zeeman levels ( m=+1)↔( m=−1) we obtained:Sr: g( P) =1.501124(10)Ba: g( D)=1.3340823 (10) g( D′)=1.1637406(11) g( D)=0.4985751(13) g( D′)=1.003 1449(10). The relativistic and diamagnetic corrections for the g factor of the P state of Sr have been calculated. With these and the Schwinger correction included we get g( P)=1.501119(12). [ABSTRACT FROM AUTHOR]
- Published
- 1975
- Full Text
- View/download PDF
6. Charge distributions of sulfur ions at energies between 70 and 140 MeV
- Author
-
Scharfer, U., Henrichs, C., Fox, J.D., Von Brentano, P., Degener, L., Sens, J.C., and Pape, A.
- Published
- 1977
- Full Text
- View/download PDF
7. Evaluation of cell survival in different 3D-printed geometric shapes of human iPSC-derived engineered heart tissue.
- Author
-
Yildirim Y, Degener L, Reuter L, Petersen J, Gabel L, Sommer A, Pahrmann C, Reichenspurner H, and Pecha S
- Subjects
- Humans, Hydrogels chemistry, Cells, Cultured, Tissue Scaffolds chemistry, Tissue Engineering methods, Myocytes, Cardiac cytology, Cell Survival, Induced Pluripotent Stem Cells cytology, Printing, Three-Dimensional
- Abstract
Objectives: Engineered Heart Tissue (EHT) is a promising tool to repair heart muscle defects and can additionally be used for drug testing. Due to the absence of an in vitro vascularization, EHT geometry crucially impacts nutrient and oxygen supply by diffusion capacity. We analyzed cardiomyocyte survival in different EHT geometries., Methods: Different geometries with varying surface-area-to-volume-ratios were calculated (structure A (Ring) AS/V = 58.47 mm
2 /440 μL3 , structure B (Infinity) 25.86 mm2 /440 μL3 ). EHTs were generated from hiPSC-derived cardiomyocytes (4 × 106 ) and a fibrin/thrombin hydrogel. Cell viability was evaluated by RT-PCR, cytometric studies, and Bioluminescence imaging., Results: Using 3D-printed casting molds, spontaneously beating EHTs can be generated in various geometric forms. At day 7, the RT-PCR analyses showed a significantly higher Troponin-T value in ring EHTs, compared to infinity EHTs. In cytometric studies, we evaluated 15% more Troponin-T positive cells in ring (73% ± 12%), compared to infinity EHTs (58% ± 11%, p = 0.04). BLI visualized significantly higher cell survival in ring EHTs (ROI = A: 1.14 × 106 p/s and B: 8.47 × 105 p/s, p < 0.001) compared to infinity EHTs during longitudinal cultivation process., Conclusion: Use of 3D-printing allows the creation of EHTs in all desired geometric shapes. The geometry with an optimized surface-area-to-volume-ratio (ring EHT) demonstrated a significantly higher cell survival measured by RT-PCR, Bioluminescence imaging, and cytometric studies using FACS analysis., (© 2024 The Author(s). Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.)- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.